Publicacións en colaboración con investigadores/as de Universidad de La Laguna (37)

2025

  1. Disease activity predicts the development of cardiovascular events in patients with rheumatoid arthritis from the CARMA cohort

    Seminars in Arthritis and Rheumatism, Vol. 75

  2. Evaluating the reliability of cardiovascular risk scales in patients with chronic inflammatory rheumatic diseases

    Seminars in Arthritis and Rheumatism, Vol. 72

  3. Performance of four cardiovascular risk scales in chronic inflammatory rheumatic disease patients: 10-year follow-up data

    Rheumatology, Vol. 64, Núm. 7, pp. 4227-4235

  4. The metabolic score for insulin resistance predicts the risk of cardiovascular disease in patients with psoriatic arthritis: results from the 10-year prospective CARMA cohort

    RMD open, Vol. 11, Núm. 1

2024

  1. Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up

    Seminars in Arthritis and Rheumatism, Vol. 66

  2. Comment on “Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease”

    Archivos de Bronconeumologia

  3. Diabetes mellitus with poor glycemic control is a risk factor for pneumonia in COPD

    Respiratory Medicine and Research, Vol. 86

  4. NeuroGPT, evaluating chatGPT: diagnosis and treatment of 72 patients

    Neurologia Argentina, Vol. 16, Núm. 3, pp. 136-141

  5. Oxygen therapy could improve survival in patients with early desaturation in the 6-minute walk test: A post hoc analysis

    Respirology

  6. Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period

    RMD open, Vol. 10, Núm. 2

2023

  1. A Novel Figure and Algorithm for the GOLD-ABE Classification: Additional Comments

    Archivos de Bronconeumologia

  2. Classification of the Severity of COPD Exacerbations in Hospitalized Patients According to Rome vs GesEPOC Criteria

    Archivos de Bronconeumologia, Vol. 59, Núm. 1, pp. 57-58

  3. Early Desaturation During 6-Minute Walk Test is a Predictor of Mortality in COPD

    Lung, Vol. 201, Núm. 2, pp. 217-224

  4. Impact of Oral Antidiabetics Agents in the Prevention of COPD Exacerbations

    Archivos de Bronconeumologia

  5. Relationship Between the Summation of GesEPOC High-Risk Factors and the Presence of Cardiovascular Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 6, pp. 403-405

  6. The Relevance of Comorbidities in the Persistence of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease

    Open Respiratory Archives, Vol. 5, Núm. 3

  7. Ultrasound assessment of diaphragmatic dynamics in patients with chronic obstructive pulmonary disease after treatment with indacaterol/glycopyrronium

    Revista Clinica Espanola, Vol. 223, Núm. 4, pp. 216-222

2022

  1. Evaluation of the multimorbidity network and its relationship with clinical phenotypes in chronic obstructive pulmonary disease: The GALAXIA study

    Clinical Respiratory Journal, Vol. 16, Núm. 7, pp. 504-512

  2. Impact of the Pandemia on Physical Activity in Patients with Chronic Obstructive Pulmonary Disease

    Open Respiratory Archives

  3. Medium- and Long-Term Consequences of SARS-CoV-2 Infection on COPD Patients

    Archivos de Bronconeumologia